Court Place Advisors LLC Sells 894 Shares of CVS Health Co. (NYSE:CVS)

Court Place Advisors LLC reduced its stake in CVS Health Co. (NYSE:CVS) by 1.7% during the 4th quarter, HoldingsChannel reports. The firm owned 51,018 shares of the pharmacy operator’s stock after selling 894 shares during the quarter. CVS Health makes up approximately 1.3% of Court Place Advisors LLC’s holdings, making the stock its 19th biggest holding. Court Place Advisors LLC’s holdings in CVS Health were worth $4,028,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of CVS. Live Oak Investment Partners bought a new stake in CVS Health during the 4th quarter worth approximately $25,000. Atticus Wealth Management LLC grew its position in CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after acquiring an additional 219 shares during the last quarter. Cornerstone Planning Group LLC grew its position in CVS Health by 111.5% during the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 243 shares during the last quarter. PCA Investment Advisory Services Inc. bought a new stake in CVS Health during the 2nd quarter worth approximately $37,000. Finally, ZRC Wealth Management LLC grew its position in CVS Health by 400.0% during the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after acquiring an additional 400 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

CVS has been the topic of several research reports. Barclays initiated coverage on CVS Health in a report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective on the stock. Piper Sandler upped their price objective on CVS Health from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Friday, March 15th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $87.00 price objective on shares of CVS Health in a report on Wednesday, April 10th. Royal Bank of Canada reduced their price objective on CVS Health from $86.00 to $84.00 and set an “outperform” rating on the stock in a report on Thursday, February 8th. Finally, Wells Fargo & Company reduced their price objective on CVS Health from $83.00 to $76.00 and set an “equal weight” rating on the stock in a report on Monday, April 8th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $89.44.

CVS Health Trading Down 0.7 %

CVS Health stock traded down $0.45 during mid-day trading on Wednesday, hitting $68.58. 8,098,555 shares of the company’s stock were exchanged, compared to its average volume of 10,906,099. The firm has a market capitalization of $86.44 billion, a P/E ratio of 10.69, a PEG ratio of 0.91 and a beta of 0.52. CVS Health Co. has a fifty-two week low of $64.41 and a fifty-two week high of $83.25. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. The company’s 50 day simple moving average is $75.68 and its 200-day simple moving average is $73.77.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping the consensus estimate of $2.01 by $0.11. The business had revenue of $93.81 billion for the quarter, compared to the consensus estimate of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm’s revenue was up 11.9% compared to the same quarter last year. During the same quarter last year, the business posted $1.99 EPS. On average, equities analysts anticipate that CVS Health Co. will post 8.32 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.88%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s payout ratio is presently 41.18%.

Insider Buying and Selling

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares in the company, valued at approximately $3,059,916.75. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.24% of the stock is currently owned by company insiders.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.